Dezima Pharma

Dezima Pharma develops novel compounds to treat cardiovascular disease related to dyslipidemia

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceuticals

Model

01Company Overview

Dezima Pharma develops novel compounds to treat cardiovascular disease related to dyslipidemia. The company is known for its best-in-class CETP inhibitor for treating cardiovascular disease.

02Backed By1 investor

BVBioGeneration Ventures→

03Similar Companies

NP

Is this your company? Claim your profile

NewAmsterdam Pharma

Biotech & Life Sciences

→

LP

Lipigon Pharmaceuticals

Biotech & Life Sciences

→

D

Dezima

Biotech & Life Sciences

→

BA

Blue Ash Therapeutics

Biotech & Life Sciences

→

QL

QroGen Life Sciences

Biotech & Life Sciences

→

04Startup DNA

7

signals

Sectors
Business Model
Technology